-
ACLA Letter to HHS on Data Reporting
-
ACLA Letter to CDC on Antibody Guidance
-
ACLA Serologic Testing White Paper
-
ACLA Letter to HHS on PHSSEF Direct COVID19 Test Funding
-
ACLA Serologic Testing Executive Summary
-
ACLA Letter To CDC on Prioritization
-
Letter to HHS on COVID-19 Provider Fund
-
ACLA Letter to Congressional Leadership on COVID-19
-
LAB Act Co-Sponsors Letter to CMS
-
ACLA Comment Letter on Reconsideration Request for the New PALB2 Full Gene Sequence CPT Code
